Stocks
H Lundbeck A/S Sponsored ADRHLUY
HealthcarePharmaceuticals
A Danish pharmaceutical company focused on brain disorders, including depression, schizophrenia, and Parkinson's disease. Its portfolio includes branded products like Rexulti and Trintellix, and it has a pipeline targeting neurology and psychiatry. Investors track HLUY for its specialty CNS franchise and its ADR listing on U.S. exchanges.
Congressional Interest in H Lundbeck A/S Sponsored ADR (HLUY)
1 member of Congress has disclosed 1 trade in H Lundbeck A/S Sponsored ADR (HLUY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading HLUY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-09-10 | Greg Gianforte | sell | $1K-$15K |